MPI Research strives to be the best CRO in preclinical and early clinical contract research.

We partner with Sponsors around the world to develop their drug and device programs. Every year, our experienced scientists and dedicated technical team conduct thousands of discovery, drug safety, bioanalytical, analytical, medical device, and clinical research studies.

We are committed to bring safer and more effective drugs and devices to the market faster and more efficiently.

With over 32,000 studies and counting and high satisfaction, MPI Research aims to be the CRO partner for your drug and device programs.

IND-enabling Packages
Conducted Annually
People Dedicated to
Improving Healthcare


“The general toxicology, DART, and pathology groups at MPI Research went above and beyond our needs and helped us obtain IND approval for our HPV therapeutic vaccine. This approval would not have been achieved without the knowledge and dedication of the MPI Research staff.”
KinKai Hwang, PhD,
HealthBanks Biotech USA Inc.
“The Study Directors at MPI Research have always been nimble and responsive to our demanding studies. They are very knowledgeable in designing and executing IND-enabling safety and toxicology studies, and produce high-quality work, and on-time data, to meet our timelines. MPI Research is not only a CRO, they are a dedicated partner that is invested in the success of our program.”
Senior Director of Product Development,
Biologics Company
“In no way should we minimize the value of the conversations I have had with the MPI Research study director; he understands our goals and asks questions that make me think. Frequent contact enables timely input and feedback. We have a tremendous relationship, and I value MPI Research’s efforts highly.”
Study Monitor,
Large Pharmaceutical Company

Read more